Primaquine is an established 8-aminoquinoline antimalarial agent indicated for the radical cure of malaria caused by Plasmodium vivax and Plasmodium ovale, as well as for the treatment of Pneumocystis… Read more




![Chemical structure of N4,N4'-(6,6'-Dimethoxy-[5,5'-biquinoline]-8,8'-diyl)bis(pentane-1,4-diamine)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F148795-90-8-N4N4-66-Dimethoxy-55-biquinoline-88-diylbispentane-14-diamine.png&w=3840&q=75)






Primaquine is an established 8-aminoquinoline antimalarial agent indicated for the radical cure of malaria caused by Plasmodium vivax and Plasmodium ovale, as well as for the treatment of Pneumocystis pneumonia. By inhibiting heme detoxification within parasites, it effectively targets intra-erythrocytic stages. Pharmaceutical laboratories rely on accurate reference standards for Primaquine API, its associated impurities, and metabolites to conduct rigorous analytical testing and quality control. These materials are essential for effective impurity profiling, helping to identify and quantify degradants during method development and validation. Furthermore, stable isotope labelled versions of the drug provide critical internal standards for quantitative analysis, particularly in mass spectrometry applications. This comprehensive range of compounds supports adherence to stringent safety and quality standards, ensuring consistency and precision throughout the analytical process in the pharmaceutical industry.